Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis

Research article (British Journal of Dermatology, 2025) · cited 11× · AI/ML
Press Enter · cited answer in seconds

Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis

Summary

Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis is a scholarly article[1].

Key Facts

  • Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis's instance of is recorded as scholarly article[2].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis. Retrieved May 24, 2026, from https://4ort.xyz/entity/living-network-meta-analysis-to-compare-nemolizumab-against-other-available-targeted-systemic-treatments-for-atopic-derm
MLA “Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/living-network-meta-analysis-to-compare-nemolizumab-against-other-available-targeted-systemic-treatments-for-atopic-derm.
BibTeX @misc{4ortxyz_living-network-meta-analysis-to-compare-nemolizumab-against-other-available-targeted-systemic-treatments-for-atopic-derm_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis}}, year = {2026}, url = {https://4ort.xyz/entity/living-network-meta-analysis-to-compare-nemolizumab-against-other-available-targeted-systemic-treatments-for-atopic-derm}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis — https://4ort.xyz/entity/living-network-meta-analysis-to-compare-nemolizumab-against-other-available-targeted-systemic-treatments-for-atopic-derm (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/living-network-meta-analysis-to-compare-nemolizumab-against-other-available-targeted-systemic-treatments-for-atopic-derm · Last refreshed: